Startups
Ride Therapeutics is solving the delivery problem for genetic medicines, unlocking the next generation of gene therapies, RNA, and gene editing.
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 10, 2026 | Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines | |
| Ride Therapeutics | “Ride Therapeutics is solving the delivery problem for genetic medicines, unlocking the next generation of gene therapies, RNA, and gene editing.” |
Reviews 0
FAQ about Ride Therapeutics
What has the press written about Ride Therapeutics?
Parsers VC has collected 3 articles mentioning Ride Therapeutics, among them “Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines” (Sep 10, 2026) and “Ride Therapeutics”.
Is Ride Therapeutics still active?
Yes, Ride Therapeutics is active; its latest activity on Parsers VC dates from Sep 20, 2026.